Clinical Research Directory
Browse clinical research sites, groups, and studies.
Opioid-free Analgesia in Intensive Care Unit
Sponsor: Centre Hospitalier Universitaire de Nīmes
Summary
ICU patients experience moderate to severe pain. Studies and guidelines point out the benefits of multimodal analgesia on pain control, opioid spare and on lowering its adverse effects. However, no recommendation about drugs or protocol has been formulated. In our study, investigators studied the feasibility and the impact on Remifentanil spare of a standardized protocol using multimodal analgesia (Paracetamol, Nefopam, Tramadol, Ketamine, Remifentanil) compared to the standard-of-care strategy using Paracetamol and Remifentanil. The investigators conducted a prospective, ''proof of concept'', randomized, double-blind, parallel group, placebo-controlled trial. The investigators studied multimodal analgesia versus standard-of-care in ICU patients requiring sedation-analgesia for invasive mechanical ventilation.The investigators hypothesized that Remifentanil consumption decrease by 15% with the use of a standardized multimodal analgesia strategy
Official title: Opioid-free Analgesia in Intensive Care Unit: a Prospective, Monocentric, Randomized, Double Blind, Feasability Clinical Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2023-05-15
Completion Date
2026-08-15
Last Updated
2025-05-28
Healthy Volunteers
No
Conditions
Interventions
OFA multimodal analgesia
Multimodal opioid free analgesia
Standard multimodal analgesia
Standard remifentanil analgesia
Locations (1)
Remy WIDEHEM
Nîmes, Gard, France